SELECTA BIOSCIENCES INC Business Finance Contracts & Agreements
30 Contracts & Agreements
- Exchange Agreements (1 contract)
- Investor Rights Agreements (1)
- Loan Agreements (6)
- Purchase Agreements (4)
- Registration Rights Agreements (5)
- Stock Agreements (4)
- Underwriting Agreements (3)
- Warrant Agreements (6)
- Form of Registration Rights Agreement (Filed With SEC on July 2, 2024)
- Securities Purchase Agreement, dated as of July 2, 2024, by and between Cartesian Therapeutics, Inc. and each purchaser identified on Annex A thereto (Filed With SEC on July 2, 2024)
- Fourth Amendment to Loan and Security Agreement, dated March 31, 2023, between Selecta Biosciences, Inc., Oxford Finance LLC, as Collateral Agent and as a lender, and Silicon... (Filed With SEC on April 4, 2023)
- Form of Amendment No. 1 to Common Stock Purchase Warrant by and between Selecta Biosciences, Inc. and certain Directors, dated December 20, 2022 (Filed With SEC on March 2, 2023)
- Third Amendment to Loan and Security Agreement, dated September 20, 2022, between Selecta Biosciences, Inc., Oxford Finance LLC, as Collateral Agent and as a Lender, and Silicon... (Filed With SEC on November 3, 2022)
- Form of Warrant (Filed With SEC on April 7, 2022)
- Underwriting Agreement, dated April 6, 2022, by and between Selecta Biosciences, Inc. and SVB Securities LLC, as representative of the several underwriters named therein (Filed With SEC on April 7, 2022)
- Second Amendment to Loan and Security Agreement, dated March 21, 2022, between Selecta Biosciences, Inc., Oxford Finance LLC, as Collateral Agent and as a lender, and Silicon... (Filed With SEC on March 22, 2022)
- First Amendment to Loan and Security Agreement, dated September 7, 2021, by and among Selecta Biosciences, Inc., Oxford Finance LLC, and Silicon Valley Bank (Filed With SEC on November 9, 2021)
- Registration Rights Agreement, dated as of June 11, 2020, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ), as amended on November 4, 2020 (Filed With SEC on November 5, 2020)
- Loan and Security Agreement, dated August 31, 2020, between Selecta Biosciences, Inc., Oxford Finance LLC, as Collateral Agent and as a lender, and Silicon Valley Bank, as a lender (Filed With SEC on September 3, 2020)
- Form of Warrant to Purchase Stock, dated August 31, 2020, issued by Selecta Biosciences, Inc. to Oxford Finance LLC and Silicon Valley Bank, together with a schedule of warrants (Filed With SEC on September 3, 2020)
- Stock Purchase Agreement, dated as of June 11, 2020, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ) (Filed With SEC on August 6, 2020)
- Registration Rights Agreement, dated as of June 11, 2020, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ) (Filed With SEC on August 6, 2020)
- Securities Purchase Agreement, dated December 18, 2019, by and among Selecta Biosciences, Inc. and the Investors named therein (Filed With SEC on December 26, 2019)
- Registration Rights Agreement, dated December 23, 2019, by and among Selecta Biosciences, Inc. and the Investors named therein (Filed With SEC on December 26, 2019)
- Form of Pre-Funded Common Stock Purchase Warrant, dated December 23, 2019 (Filed With SEC on December 26, 2019)
- Form of Common Stock Purchase Warrant, dated December 23, 2019 (Filed With SEC on December 26, 2019)
- Stock Purchase Agreement, dated August 19, 2019, by and among Selecta Biosciences, Inc. and the Investors named therein (Filed With SEC on August 20, 2019)
- Underwriting Agreement, dated January 23, 2019, between the Company and Stifel, Nicolaus & Company, Incorporated, as representative of the several underwriters named therein (Filed With SEC on January 24, 2019)
- Loan and Security Agreement, dated September 12, 2017, between Selecta Biosciences, Inc. and Silicon Valley Bank (Filed With SEC on September 13, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 28, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 28, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 28, 2017)
- THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANT (Filed With SEC on June 28, 2017)
- PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT - EXCLUSIVE This Agreement is based on the model Patent License Exclusive Agreement adopted by the U.S. Public Health Service (PHS)... (Filed With SEC on May 11, 2017)
- STOCK PURCHASE AGREEMENT (Filed With SEC on December 14, 2016)
- SELECTA BIOSCIENCES, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE (Filed With SEC on June 8, 2016)
- FIFTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on June 8, 2016)
- SELECTA BIOSCIENCES, INC. Shares Common Stock ($0.0001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on June 8, 2016)
